Background
==========

Although thyroiditis can occur following parathyroidectomy surgery, it is not a commonly recognised clinical complication. This phenomenon has been described in the literature as 'palpation thyroiditis' ([@bib1]). The mechanism has not been fully elucidated but several theories have been proposed. Intraoperative trauma by vigorous palpation of the gland causing rupture of isolated thyroid follicles is the most commonly postulated mechanism. The risk appears to increase with the extent of neck exploration surgery ([@bib2], [@bib3]), but palpation thyroiditis has also been described in patients undergoing surgery for primary hyperparathyroidism ([@bib4], [@bib5]). Palpation of the thyroid gland causing impairment of the physical integrity of the follicular epithelium and a subsequent inflammatory process otherwise termed 'multifocal granulomatous folliculitis' has also been hypothesised as a causal mechanism ([@bib4]). Histologically this is characterised by an infiltrate with histiocytes, plasma cells, lymphocytes and haemosiderin-laden macrophages ([@bib6]).

The majority of patients with palpation thyroiditis are clinically asymptomatic and only a minority develop symptoms of overt thyrotoxicosis. The incidence of TSH suppression in clinically asymptomatic patients is much higher. Studies have reported biochemical hyperthyroidism, defined as full TSH suppression, occurring after parathyroidectomy in as many as 31--42% of patients, whereas only \~15% are symptomatic ([@bib5]). The variability in incidence rates may be accounted for by (i) the primary indication for surgery; (ii) varying operative techniques used for primary, secondary and tertiary hyperparathyroidism; (iii) the extent of intraoperative gland manipulation; and (iv) variations in thyroid shape, size and pre-operative function ([@bib5]).

Abnormal values of TSH, free T~4~ (fT~4~) and free T~3~ (fT~3~) indicating post-operative thyrotoxicosis are observed in patients with palpation thyroiditis. The levels of fT~4~ and fT~3~ usually reach their maximum on post-operative day 1--3, whereas the TSH nadir occurs around post-operative day 5 ([@bib5]). Thyroglobulin released from the injured thyroid follicles also increases, and has been suggested as a suitable marker supporting the diagnosis. Thyroglobulin levels greater than 90ng/mL are suggestive of post-operative palpation thyroiditis ([@bib5]). Spontaneous resolution can be expected by 6weeks in the vast majority of patients given that the half-life of fT~4~ is one week (i.e. 5--6 half-lives until resolution) ([@bib3]). Persistence thereafter should prompt the clinician to search for an alternative cause of hyperthyroidism.

We report a case of a patient who underwent subtotal parathyroidectomy for tertiary hyperparathyroidism, which was complicated by thyroiditis causing symptomatic thyrotoxicosis. This is the first published case report of such early thyrotoxicosis as supported by a TSH nadir by day 5 post-operatively and absence of tracer uptake on a Tc-99m pertechnetate thyroid scan.

Case presentation
=================

A 37-year-old man with tertiary hyperparathyroidism in the setting of end-stage renal failure secondary to hypertension and a unilateral kidney was electively admitted for a subtotal parathyroidectomy. He had no history of thyroid disease and had not received any iodinated contrast agents or iodine-containing medications before the operation. He gave no history of neck pain, recent fever or neck irradiation. There was no family history of thyroid disease.

Pre-operatively he was biochemically euthyroid with serum TSH 1.38mU/L (reference range: 0.30--5.00), fT~4~ 12.0pmol/L (reference range, 9.1--19.6) and fT~3~ 1.8pmol/L (reference range: 2.4--5.9). As part of the pre-operative workup the patient also underwent a thyroid ultrasound demonstrating a mildly heterogeneous nodular appearance of both lobes. The right lobe measured 16×16×51mm and the left lobe measured 17×10×44mm. The largest nodule in the left thyroid lobe was a well-circumscribed 19×12×12mm lesion at the junction with the isthmus. This was biopsied and the histopathology was consistent with a benign colloid cyst. Within the right thyroid lobe, there were two nodules, one measuring 5×5×9mm and the other measuring 7×6×21mm. Both had similar appearances and were suggestive of parathyroid adenomas. The patient went on to have a sestamibi scan, which suggested multinodular changes but no scintigraphic evidence of a parathyroid adenoma.

He underwent subtotal parathyroidectomy. There was difficulty with dissection and mobilisation of the left inferior parathyroid gland, which was densely adhering to the surrounding tissues. In total, three and a half parathyroid glands were excised and the total operative time was approximately one and a half hours. Histopathology confirmed the presence of parathyroid tissue with uniformly round typical nuclei and no areas of necrosis or fibrous septae.

On post-operative day 1, the patient developed irritability, palpitations, insomnia and vivid dreams. Physical examination revealed signs of thyrotoxicosis including diaphoresis, a resting sinus tachycardia with a heart rate of 130--150 beats per minute, bilateral hand tremor and globally brisk reflexes. There was no goitre, neck tenderness, thyroid bruit or signs of thyroid ophthalmopathy.

Laboratory investigations were consistent with thyrotoxicosis with a partially suppressed serum TSH of 0.16mU/L (reference range: 0.30--5.00), elevated fT~4~ of 37.8pmol/L (reference range: 9.1--19.6) and fT~3~ of 5.5pmol/L (reference range: 2.4--5.9), and elevated thyroglobulin of 255.4μg/L (reference range: 3.5--77). Anti-thyroid peroxidase antibody testing was negative. The TSH became completely suppressed by the post-operative day 5 with a persistently elevated fT~4~ of 22.6pmol/L and normal fT~3~ of 3.3pmol/L.

A Tc-99m pertechnetate thyroid scan showed diffusely decreased radiotracer uptake throughout both lobes of the thyroid gland with overall thyroid gland uptake significantly lower than background salivary gland uptake. The features overall were in keeping with thyroiditis ([Fig. 1](#fig1){ref-type="fig"}).Figure 1Technetium-99m scintigraphy scan of the thyroid gland. The radiotracer uptake is diffusely decreased throughout both lobes of the thyroid gland with overall thyroid uptake significantly less than background salivary gland uptake. Features are in keeping with thyroiditis.

Investigations
==============

Refer to the preceding case presentation for biochemical results.

Treatment
=========

The patient was treated symptomatically with up-titration of his regular dose of metoprolol from 50mg BD to 150mg BD with rapid and good effect.

Outcome and follow-up
=====================

Fourteen days after the operation, the patient was reviewed in the outpatient clinic with repeat laboratory investigations. These demonstrated complete resolution with TSH 2.11mU/L (reference range: 0.30--5.00), fT~4~ 16.6pmol/L (reference range: 9.1--19.6), fT~3~ 4.7pmol/L (reference range: 2.4--5.9) and thyroglobulin 21.2μg/L (reference range, 3.5--77). His metoprolol dose was reduced to baseline 50mg BD. Subsequent thyroid function tests 4weeks later showed he remained euthyroid, and there was no documented hypothyroid phase of his illness.

Discussion
==========

Palpation thyroiditis causes transient hyperthyroidism and can occur as a complication of surgery for hyperparathyroidism. It reflects release of preformed hormone from damaged follicular cells, but may also occur because of alteration in the integrity of the follicular basement membrane. Biochemically, a large proportion of patients are hyperthyroid following surgery; however, a much smaller proportion of patients are symptomatic. This may suggest the possibility of under-diagnosis due to the high prevalence of asymptomatic disease. This may have clinical implications such as exacerbation of pre-existing coronary heart disease or precipitation of atrial arrhythmias ([@bib7]). In a prospective study by Stang *et al*., the majority of 125 patients had biochemical evidence of hyperthyroidism after parathyroidectomy, and the majority of them were asymptomatic or mildly symptomatic ([@bib3]).

Rudofsky *et al*. ([@bib7]) evaluated 39 patients undergoing surgery for secondary hyperparathyroidism in the context of end-stage renal failure with pre- and post-operative thyroid function tests. Thirty of the 39 patients with normal preoperative serum TSH, fT~4~ and fT~3~ displayed post-operative biochemical evidence of hyperthyroidism, and 60% of these patients were symptomatic. Maximum levels of fT~4~ and fT~3~ were reached on post-operative days 1--3, and the TSH nadir was reached by day 5. By day 40, there was spontaneous resolution of clinical symptoms and biochemical normalisation in all cases with no significant long-term sequelae reported.

We report a case of a man with significant symptoms consistent with overt thyrotoxicosis in the immediate days after successful and otherwise uncomplicated parathyroid surgery. Suppressed TSH, elevated fT~4~, fT~3~ and thyroglobulin levels and reduced scan uptake aided in diagnostic clarification. Thyrotoxicosis in our patient is suspected to have resulted from intraoperative palpation of the gland resulting in palpation thyroiditis.

As demonstrated, there is potential for harm, particularly in the early period, in patients who develop overt thyrotoxicosis following parathyroid surgery who are undiagnosed and left untreated. When necessary, beta-adrenergic antagonists may be required to control symptoms of overt thyrotoxicosis and prevent further deterioration. Awareness of this complication of surgery is also important to avoid unnecessary and potentially harmful investigations and treatments to patients with otherwise unexplained adrenergic symptoms in the post-operative period. Clinicians should be encouraged to counsel patients about thyroiditis and thyrotoxicosis as potential risks following parathyroid surgery and to perform routine biochemical surveillance if clinically indicated.

Declaration of interest
=======================

There is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Funding
=======

This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Patient consent
===============

Written informed consent was obtained from the patient for publication of this case report.

Author contributions and acknowledgements
=========================================

Dr Elizabeth Madill -- Basic Physician Trainee, worked with the Department of Renal Medicine at Alfred Health and looked after the patient while he was an inpatient and was the principal author of this manuscript. Dr Shamil Cooray -- Advanced Trainee in Endocrinology, worked with the Department of Endocrinology and Diabetes at Alfred Health, reviewed the patient in outpatient clinic, and assisted Dr Madill with the literature review and in editing of the case report and discussion. Prof Leon Bach -- Consultant Endocrinologist and Deputy Director of the Department of Endocrinology and Diabetes was the treating endocrinologist during his admission and supervised Dr Madill in editing of the case report and discussion.
